bizjournals.com | Submitted by jjc, 08.04.09
A new research laboratory established at Beth Israel Deaconess Medical Center will enable cancer specialists to characterize molecular abnormalities in individual melanomas and help physicians provide more personalized treatment and clinical research approaches.